Biotech Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 21, 2026
Biotech BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026 August 20, 2026
Biotech Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline August 20, 2026
Biotech IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer August 19, 2026
Biotech Invitation to presentation of BioArctic’s second quarter report for April – June 2026 on August 26 at 9:30 a.m. CEST August 19, 2026
Biotech Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development August 19, 2026
Biotech Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia August 18, 2026
Biotech Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights August 18, 2026